DigitalHealthJapan List of articles

2025.06.25

White,medical,pills,and,tablets,spilling,out,of,a,drug

JPMA Responds to the 2025 Honebuto Policy: Emphasizing Reform of Cost-Effectiveness Evaluation and Pricing Framework

Introduction to Japan’s 2025 Honebuto Policy  According to a news article (製薬協 費用対効果評価「現行の枠組みにとらわれない新たな制度 […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
Phone:+81-3-6304-5570